Oral Chondroprotective Agents. Part II. Evaluation of Products

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 21, Issue 9, 1999, Pages 861-865

  Anderson, Mark A ^a,b  

^a Veterinary Specialty Services   (United States)

^b Amer College of Veterinary Surgeons   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347784917     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Boothe DM: Nutraceuticals in veterinary medicine. Part I. Definitions and regulations. Compend Contin Educ Pract Vet 19(11):1248-1255, 1997.
2. Boothe DM: Nutraceuticals in veterinary medicine. Part II. Safety and efficacy. Compend Contin Educ Pract Vet 20(1): 15-21, 1998.
3. Dzanis DA: Nutraceuticals: Food or drug? Proc TNAVC: 430-433, 1998.
4. Plumbs M: Cartilage supplements help treat arthritis. Michael Plumb's Horse J 4:3-11, 1997.
5. Beale BS: Evaluation of active enzyme in six oral superoxide dismutase products. Proc Vet Orthop Soc.65, 1998.
6. Deal C, Moskowitz RW: Nutraceuticals as therapeutic agents in osteoarthritis: The role of glucosamine, chondroitin sulfate and collagen hydrolysate. Rheum Dis Clin North Am 25:379-395, 1999.
7. Hulse DS: Treatment methods for pain in the osteoarthritic patient. Vet Clin North Am Small Anim Pract 28:361, 1998.
8. McNamara PS, Johnston SA, Todhunter RJ: Disease-modifying osteoarthritic agents. Vet Clin North Am Small Anim Pract 27:863-867, 1997.
9. Boothe DM: Pharmacology: Nutraceuticals: The good, the bad, and the ugly. Proc AAHA:292-295, 1998.
10. Das A: The biochemistry of cartilage and osteoarthritis treatment options. Orthoped Special Ed 5:1-4, 1999.
11. Bourgeois P, Chales G, Dehais J, et al: Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs. chondroitin sulfate 3 × 400 mg/day vs. placebo. Osteoarthr Cartilage 6:25-30, 1998.
12. Busci L, Poor G: Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis in the treatment of knee osteoarthritis. Osteoarthr Cartilage 6:31-36, 1998.
13. Verbruggen G, Goemaere S, Veys EM: Chondroitin sulfate: Structure/disease modifying antiosteoarthritis drug in the treatment of finger joint osteoarthritis. Osteoarthr Cartilage 6:37-38, 1998.
14. Uebelhart D, Thonar EJ, Delmas PD, et al: Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: A pilot study. Osteoarthr Cartilage 6:39-46, 1998.
15. Coughlan A: Is there a role for oral glucosamine and chondroitin sulphate supplements in managing the osteoarthritic patient?, in Coughlan A (ed): Coughlan Orthopedics. Cheshire, England, Neston, 1997, pp 24-28.
16. Bucci L: Glycosaminoglycans, in Bucci L (ed): Nutrition Applied to Injury Rehabilitation and Sports Medicine. Boca Raton, FL, CRC Press, 1995, pp 177-203.
17. Belfield WO: Complementary and alternative veterinary medicine, in Schoen AM, Wynn SG (eds): Complementary and Alternative Veterinary Medicine. Philadelphia, Mosby, 1998, pp 113-129.
18. Fontenele JB, Araujo GB, de Alencar JW, et al: The analgesic and anti-inflammatory effects of shark cartilage are due to a peptide molecule and nitric acid (NO) system dependent. Biol Pharm Bull 20:1151-1154, 1997.
19. Glycoflex brochure, Code V-7-0794-R. Essex Junction, VT, Vetri-Science Laboratories.
20. Miller TE, Dodd J, Ormrod DJ, et al: Anti-inflammatory activity of glycogen extracted from Perna canaliculus (NZ green-lipped mussel). Agents Actions 38:C139-C142, 1993.
21. Larkin JG, Capell HA, Sturrock RD: Seatone in rheumatoid arthritis: A six-month placebo-controlled study. Ann Rheumatic Dis 44:199-201, 1985.
22. Champe PC, Harvey RA: Glycosaminoglycans, in Champe PC, Harvey RA (eds): Lippincott's Illustrated Review of Biochemistry. Philadelphia, JB Lippincott, 1994, pp 147-162.
23. Trentham DE, Dynesius-Trentham RA, Orav EJ, et al: Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261:1727-1730, 1993.
24. Johnson S: Osteoarthritis: Joint anatomy, physiology and pathobiology. Vet Clin North Am Small Anim Pract 27:699-723, 1997.
25. Barnett ML, Combitchi D, Trentham DE: A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis. Arthritis Rheumatol 39:623-628, 1996.
26. Bari SM, Carter SD, Bell SC, et al: Anti-type II collagen antibody in naturally occurring canine joint diseases. Br J Rheumatol 28:480-486, 1989.
27. Niebauer GW, Wolf B, Bashey RI, et al: Antibodies to canine collagen types I and II in dogs with spontaneous cranial cruciate ligament rupture and osteoarthritis. Arthritis Rheumatol 30:319-327, 1987.
28. Zurier B: Essential fatty acids and inflammation. Ann Rheumatic Dis 50:745-746, 1991.
29. Ackerman L: Dermatologic uses of fatty acids in dogs and cats. Vet Med 90:1149-1155, 1995.
30. Bucci L: Fats: Fatty acids and lipids, in Bucci L (ed): Nutrition Applied to Injury Rehabilitation and Sports Medicine. Boca Raton, FL, CRC Press, 1995, pp 53-58.
31. Bucci L: Ultratrace minerals, in Bucci L (ed): Nutrition Applied to Injury Rehabilitation and Sports Medicine. Boca Raton, FL, CRC Press, 1995, pp 162-166.
32. Heinle K, Adam A, Gradl M, et al: Selenium concentration in erythrocytes of patients with rheumatoid arthritis. Med Klin 92:29-31, 1997.
33. Peterkofsky B, Palka J, Wilson L, et al: Elevated activity of low molecular weight insulin-like growth factor binding proteins in sera of vitamin C deficient and fasted guinea pigs. Endocrinology 128:1769-1779, 1991.
34. Bucci L: Normal cellular components: Proteins, nucleic acids and antioxidant enzymes, in Bucci L (ed): Nutrition Applied to Injury Rehabilitation and Sports Medicine. Boca Raton, FL, CRC Press, 1995, pp 167-176.
35. Bosco C, Tihanyi J, Pucspk J, et al: Effect of oral creatine supplementation on jumping and running performance. Int J Sports Med 18:369-372, 1997.
36. Craig RP: The quantitative evaluation of the use of oral proteolytic enzymes in the treatment of sprained ankles. Injury 6:313-316, 1975.
37. Trickett P: Proteolytic enzymes in the treatment of athletic injuries. Appl Ther 6:647, 1964.